Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

NCT04387461

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • University of California - San Diego La Jolla, California, United States
  • University of California - Irvine Orange, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Tampa, Florida, United States
View all 19 locations
View Trial Details
Completed

Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +21 more
Locations
  • Birmingham VA Medical Center, Birmingham, AL Birmingham, Alabama, United States
  • Atlanta VA Medical and Rehab Center, Decatur, GA Decatur, Georgia, United States
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States
  • Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond, Virginia, United States
View Trial Details
Completed

Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NCT03532451

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Urology Centers of Alabama (UCA) Homewood, Alabama, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Medication Management Greensboro, North Carolina, United States
  • Urology Associates, P.C. Nashville, Tennessee, United States
View Trial Details
Completed

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Completed

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

NCT00981656

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Emory Crawford Long Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • St. Agnes Hospital Cancer Center Baltimore, Maryland, United States
  • Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer

NCT05399004

Conditions
Bladder Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Louisiana State University Lafayette, Louisiana, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 14 locations
View Trial Details

Related conditions